Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years.
The report is available by section, and can be customized to specific information needs and budget.
The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
Comprehensive market segmentation analysis, including:
Test volume forecasts for over 40 major procedures by market segment.
Current and Emerging Products
Review of established and emerging procedures.
Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
Technology Review
Analysis of current and emerging technologies and their potential market applications.
Comprehensive lists of companies developing or marketing new technologies and products by test.
Strategic Recommendations
Product development and business expansion opportunities with significant market appeal.
Ideal product models with tentative prices and operating characteristics.
Alternative market penetration strategies for instrument and reagent suppliers.
Potential market entry barriers and risks.
Contains 424 pages and 37 tables
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years.
The report is available by section, and can be customized to specific information needs and budget.
The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
Comprehensive market segmentation analysis, including:
- Hospitals
- Commercial/Private Laboratories
- Physician Offices
Test volume forecasts for over 40 major procedures by market segment.
Current and Emerging Products
Review of established and emerging procedures.
Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
Technology Review
Analysis of current and emerging technologies and their potential market applications.
Comprehensive lists of companies developing or marketing new technologies and products by test.
Strategic Recommendations
Product development and business expansion opportunities with significant market appeal.
Ideal product models with tentative prices and operating characteristics.
Alternative market penetration strategies for instrument and reagent suppliers.
Potential market entry barriers and risks.
Contains 424 pages and 37 tables
Companies Mentioned
- Abbott
- Accriva
- Axis-Shield
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data
- Chrono-Log
- Corgenix
- Diagnostica Stago/Trinity Biotech
- Grifols
- Helena Laboratories
- HYPHEN BioMed
- Instrumentation Laboratory/Werfen
- Roche
- Sekisui Diagnostics
- Siemens Healthineers
- Sienco
- Sysmex
- Thermo Fisher
